معرفی
Robert Schoen, MD, MBA, is a Clinical Professor in the Department of Internal Medicine at Yale School of Medicine, specializing in Rheumatology. His clinical expertise includes rheumatoid arthritis, psoriatic arthritis, and Lyme disease. With a career spanning over four decades, he holds an MD from Columbia University (1976), an AB in Biochemical Sciences from Harvard (1972), and an MBA from the University of Connecticut (2001). His research focuses on viral arthritis (particularly chikungunya and Lyme disease), postinfectious inflammatory conditions, and therapeutic interventions for chronic arthritic conditions.
Dr. Schoen’s research has produced over 30 peer-reviewed publications, including seminal works on chikungunya arthritis pathogenesis, Lyme disease management, and methotrexate efficacy. Notable contributions include a 2025 systematic review linking chikungunya fever to rheumatoid arthritis and a 2024 randomized trial evaluating methotrexate/dexamethasone treatment for chikungunya arthritis. His work bridges clinical practice and translational research, emphasizing patient-centered care and global health implications.
Recognitions include designation as a Master of the American College of Rheumatology (2023) and inclusion in multiple ‘Top Doctors’ lists. His academic leadership includes roles in residency training at Yale New Haven Hospital and fellowships at Brigham and Women’s Hospital (1981). Ongoing efforts focus on improving diagnostic accuracy and therapeutic strategies for emerging and chronic rheumatologic conditions.
- Education: AB Harvard (1972), MD Columbia (1976), MBA UConn (2001)
- Board Certifications: Rheumatology and Internal Medicine (ABIM)
- Awardees: Master of the American College of Rheumatology, 2023 ‘Top Doctors’ (Yale Medicine)